The nurse is providing instructions to the patient diagnosed with Multiple Sclerosis (MS) about baclofen. What would the nurse emphasize in the instructions?

A. Encourage the patient to write questions on a white erase board: While writing on a whiteboard can be a helpful method of communication for some patients with ALS, it may not be effective as the disease progresses. In the later stages of ALS, patients often lose the ability to use their hands or arms, making writing impossible.

B. Use pre-arranged eye signals because eye muscles remain intact: In the later stages of ALS, most voluntary muscle function is lost, except for eye muscles. Using eye movements or pre-arranged eye signals (e.g., blinking or moving eyes up or down) is an effective way to communicate with patients who can no longer speak or write. The nurse can establish a system of eye signals to communicate with the patient.

C. Speak slow and repeat phrases due to cognitive decline: ALS typically does not cause cognitive decline. It primarily affects motor function. Speaking slowly and repeating phrases may be helpful if the patient is struggling with speech, but cognitive impairment is not a common symptom in ALS.

D. Have the patient squeeze the nurse's hand when intubated and on the ventilator: When a patient is intubated and on a ventilator, they may not be able to effectively squeeze the nurse's hand due to the presence of a tube in their airway. Additionally, the ability to use hand movements may be lost in advanced ALS, making this method of communication unreliable.

A. Difficulty swallowing and speaking associated with descending muscle weakness: Amyotrophic lateral sclerosis (ALS) primarily affects motor neurons, leading to progressive muscle weakness. Difficulty swallowing (dysphagia) and speaking (dysarthria) are common symptoms, and these occur as the muscle weakness affects the tongue, throat, and other muscles responsible for these functions. The weakness typically starts in the limbs and then progresses to involve other areas of the body.

B. Movement and behavioral unpredictability with declining cognitive abilities: While ALS primarily affects motor function, some patients may experience mild cognitive changes or frontotemporal dementia (FTD), but this is not a characteristic feature for most individuals. Behavior and cognitive decline are not typically seen in the majority of ALS cases.

C. Muscle weakness starting in bilateral legs with weakness ascending upwards: This description is more consistent with Guillain-Barré Syndrome (GBS), which often presents with ascending muscle weakness that starts in the lower limbs. In ALS, muscle weakness generally starts in one area (e.g., a limb) and progresses asymmetrically, rather than ascending in a symmetrical pattern.

D. Ptosis, fatigue, and generalized muscle weakness: Ptosis (drooping eyelids) is not a primary or common symptom of ALS. While generalized muscle weakness and fatigue are common in ALS, ptosis is more characteristic of other neuromuscular disorders such as myasthenia gravis.